High-dose interleukin-2 in metastatic renal cell carcinoma - Reply

被引：0
|
作者：
McDermott, DF [1 ]
Atkins, MB
Regan, MM
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 27期
关键词：
D O I：
10.1200/JCO.2005.02.2756
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6798 / 6799
页数：2
相关论文
共 50 条
  • [1] High-dose interleukin-2 in metastatic renal cell carcinoma
    Fernández-Rodríguez, R
    de Argumedo, GL
    Mañé, JM
    Muñoz, A
    Ferreiro, J
    Fuente, N
    López-Vivanco, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6797 - 6798
  • [2] The application of high-dose interleukin-2 for metastatic renal cell carcinoma
    McDermott, David F.
    [J]. MEDICAL ONCOLOGY, 2009, 26 : 13 - 17
  • [3] The application of high-dose interleukin-2 for metastatic renal cell carcinoma
    David F. McDermott
    [J]. Medical Oncology, 2009, 26 : 13 - 17
  • [4] High-dose interleukin-2 in metastatic disease: Renal cell carcinoma and melanoma
    Dutcher, J
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (11): : 3 - 3
  • [5] HIGH-DOSE INTERLEUKIN-2 IN THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA
    PARKINSON, DR
    SZNOL, M
    [J]. SEMINARS IN ONCOLOGY, 1995, 22 (01) : 61 - 66
  • [6] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Vieweg, J
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (04): : 192 - 193
  • [7] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Johannes Vieweg
    [J]. Nature Clinical Practice Oncology, 2005, 2 : 192 - 193
  • [8] High-dose interleukin-2 therapy for metastatic renal cell carcinoma: A contemporary experience
    Aboumohamed, Ahmed A.
    Yarlagadda, Naveen
    Creighton, Terrance
    Mehedint, Diana
    Attwood, Kristopher
    Kauffman, Eric
    George, Saby
    Khushalani, Nikhil I.
    Pili, Roberto
    Schwaab, Thomas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] High-dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma: A Contemporary Experience
    Hanzly, Michael
    Aboumohamed, Ahmed
    Yarlagadda, Naveen
    Creighton, Terrance
    Digiorgio, Lorenzo
    Fredrick, Ariel
    Rao, Gaurav
    Mehedint, Diana
    George, Saby
    Attwood, Kristopher
    Kauffman, Eric
    Narashima, Deepika
    Khushalani, Nikhil I.
    Pili, Roberto
    Schwaab, Thomas
    [J]. UROLOGY, 2014, 83 (05) : 1129 - 1134
  • [10] High-Dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma and Metastatic Melanoma: Still the Standard
    Dutcher, Janice P.
    [J]. ONCOLOGY-NEW YORK, 2011, 25 (05): : 427 - 428
12345